What is the current PRFN.SW stock price and intraday change?

PRFN.SW stock is trading at **CHF 0.0362** on 19 Feb 2026, down **8.12%** from the prior close of **CHF 0.0394**, with volume **2,937,350.00** shares.

What drivers should investors watch for PRFN.SW stock?

Watch clinical updates for KIN001, licensing announcements, and any capital raises. In micro-cap names like PRFN.SW stock, news flow and liquidity swings usually drive the largest moves.

How does Meyka AI grade affect PRFN.SW stock analysis?

Meyka AI rates PRFN.SW with a score of **60.40 / 100** (Grade B, HOLD). The grade factors in benchmark and sector comparisons, financial growth, key metrics, and analyst signals to add context to risk assessment.

What is the Meyka AI forecast for PRFN.SW stock?

Meyka AI's forecast model projects **CHF 0.0500** for PRFN.SW stock. Compared with the current price of **CHF 0.0362**, that implies about **38.12%** upside. Forecasts are projections and not guarantees.

CH Stocks

Down 8.12% intraday 19 Feb 2026: Kinarus (PRFN.SW, SIX) 2.94M shares active

ByHuzaifa Zahoor February 19, 2026February 19, 2026

PRFN.SW stock is trading at CHF 0.0362 as of intraday trade on 19 Feb 2026, down 8.12% from the previous close. Volume is elevated at 2,937,350.00 shares, roughly 3.42x the average, which makes PRFN.SW stock one of the most active names on the SIX today. The move follows no scheduled earnings release, so traders are reacting to liquidity and micro-cap flows. We review price drivers, fundamentals, and short-term scenarios for Kinarus Therapeutics Holding AG on the Switzerland exchange.